BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND ITK, PSCTK2, 3702, Q08881, ENSG00000113263, EMT, MGC126258, LYK, MGC126257 AND Treatment
217 results:

  • 1. Elevated INHBA Promotes Tumor Progression of Cervical cancer.
    Wu Z; Chen J; Yang L; Sun K; Jiang Q; Dong F; Lu W; Chen R; Chen Y
    Technol Cancer Res Treat; 2024; 23():15330338241234798. PubMed ID: 38419562
    [No Abstract]    [Full Text] [Related]  

  • 2. Investigation of in-vitro Anti-cancer and Apoptotic Potential of Garlic-Derived Nanovesicles against Prostate and Cervical cancer Cell Lines.
    Sharma V; Sinha ES; Singh J
    Asian Pac J Cancer Prev; 2024 Feb; 25(2):575-585. PubMed ID: 38415544
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Atractylodes macrocephala III suppresses emt in cervical cancer by regulating IGF2BP3 through ETV5.
    Wang M; Meng J; Wang H; Hu H; Hong Y
    J Cell Mol Med; 2024 Feb; 28(4):e18081. PubMed ID: 38358034
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. HPV16 E6 promoting cervical cancer progression through down-regulation of miR-320a to increase TOP2A expression.
    Zhang J; Yu X; Guo Y; Wang D
    Cancer Med; 2024 Feb; 13(3):e6875. PubMed ID: 38205938
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. cancer susceptibility 18 positively regulates NUAK Family Kinase 1 expression to promote migration and invasion via sponging of miR-5586-5p in cervical cancer cells.
    Wang J; Zhang B; Gong S; Liu Y; Yi L; Long Y
    Int J Immunopathol Pharmacol; 2023; 37():3946320231223310. PubMed ID: 38131232
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Exploring the significance of tumor volume in endometrial cancer: Clinical pathological features, prognosis, and adjuvant therapies.
    Fan Z; Sun X; Han X; Sun C; Huang D
    Medicine (Baltimore); 2023 Dec; 102(50):e36442. PubMed ID: 38115321
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. LMP2 and TAP2 impair tumor growth and metastasis by inhibiting Wnt/β-catenin signaling pathway and emt in cervical cancer.
    Cheng Z; Wang H; Yang Z; Li J; Chen X
    BMC Cancer; 2023 Nov; 23(1):1128. PubMed ID: 37986152
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. HIV gp120/Tat protein-induced epithelial-mesenchymal transition promotes the progression of cervical lesions.
    Wang P; Yang B; Huang H; Liang P; Long B; Chen L; Yang L; Tang L; Huang L; Liang H
    AIDS Res Ther; 2023 Nov; 20(1):82. PubMed ID: 37981694
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Metformin exhibits antineoplastic effects on Pten-deficient endometrial cancer by interfering with TGF-β and p38/ERK MAPK signalling.
    Ruiz-Mitjana A; Vidal-Sabanés M; Navaridas R; Perramon-Güell A; Yeramian A; Nicholson-Sabaté N; Egea J; Encinas M; Matias-Guiu X; Dolcet X
    Biomed Pharmacother; 2023 Dec; 168():115817. PubMed ID: 37925934
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Lipid reprogramming induced by the NNMT-ABCA1 axis enhanced membrane fluidity to promote endometrial cancer progression.
    Wen Q; Xie X; Chen C; Wen B; Liu Y; Zhou J; Lin X; Jin H; Shi K
    Aging (Albany NY); 2023 Oct; 15(21):11860-11874. PubMed ID: 37889548
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Pathogenomics model for personalized medicine in cervical cancer: Cross-talk of gene expressions and pathological images related to oxidative stress.
    Li J; Chen S; Wu J; Liu X; Liu H; Liu Y; Zhu Z
    Environ Toxicol; 2024 Feb; 39(2):751-767. PubMed ID: 37755325
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Methionine enkephalin inhibited cervical cancer migration as well as invasion and activated CD11b
    Qu N; Meng Y; Zhai J; Griffin N; Shan Y; Gao Y; Shan F
    Int Immunopharmacol; 2023 Nov; 124(Pt B):110967. PubMed ID: 37741126
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. An emt-related genes signature as a prognostic biomarker for patients with endometrial cancer.
    Yu Y; Zhang Y; Li Z; Dong Y; Huang H; Yang B; Zhao E; Chen Y; Yang L; Lu J; Qiu F
    BMC Cancer; 2023 Sep; 23(1):879. PubMed ID: 37723477
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. miR-638 suppresses cervical cancer progression by inhibiting
    Wang M; Liu K; Zhou Z; Geng H
    Histol Histopathol; 2024 Apr; 39(4):497-509. PubMed ID: 37702425
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Ginsenosides in endometrium-related diseases: Emerging roles and mechanisms.
    Zhang YY; Li MZ; Shen HH; Abudukeyoumu A; Xie F; Ye JF; Xu FY; Sun JS; Li MQ
    Biomed Pharmacother; 2023 Oct; 166():115340. PubMed ID: 37625321
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Knockdown of miR-24 Suppressed the Tumor Growth of Cervical Carcinoma Through Regulating PTEN/PI3K/AKT Signaling Pathway.
    He H; Lin C; Lu Y; Wu H
    Biochem Genet; 2024 Apr; 62(2):1277-1290. PubMed ID: 37589947
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. EGCG attenuate EGF triggered matrix abundance and migration in HPV positive and HPV negative cervical cancer cells.
    Sabanayagam R; Krishnamoorthy S; Gnanagurusamy J; Muruganatham B; Muthusami S
    Med Oncol; 2023 Aug; 40(9):261. PubMed ID: 37544940
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Netrin-1 blockade inhibits tumour growth and emt features in endometrial cancer.
    Cassier PA; Navaridas R; Bellina M; Rama N; Ducarouge B; Hernandez-Vargas H; Delord JP; Lengrand J; Paradisi A; Fattet L; Garin G; Gheit H; Dalban C; Pastushenko I; Neves D; Jelin R; Gadot N; Braissand N; Léon S; Degletagne C; Matias-Guiu X; Devouassoux-Shisheboran M; Mery-Lamarche E; Allard J; Zindy E; Decaestecker C; Salmon I; Perol D; Dolcet X; Ray-Coquard I; Blanpain C; Bernet A; Mehlen P
    Nature; 2023 Aug; 620(7973):409-416. PubMed ID: 37532934
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Transferrin receptor modulated by microRNA-497-5p suppresses cervical cancer cell malignant phenotypes.
    Fang X; Hu P; Gao Y; Chen C; Xu J
    Adv Clin Exp Med; 2024 Mar; 33(3):273-282. PubMed ID: 37486696
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Circ_0001589/miR-1248/HMGB1 axis enhances emt-mediated metastasis and cisplatin resistance in cervical cancer.
    Ma T; Guo J; Han J; Li L; Ren Y; Huang J; Diao G; Zheng X; Zheng Y
    Mol Carcinog; 2023 Nov; 62(11):1645-1658. PubMed ID: 37431919
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 11.